3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Lymphoma
5
Central Nervous System Neoplasms
4
Neuroblastoma
2
Meningeal Carcinomatosis
2
Brain Neoplasms
2
Vasculitis, Central Nervous System
1
Thrombocytopenia
1
Stiff-Person Syndrome
1
Rhabdoid Tumor
1
Recurrence
1
Rasmussen subacute encephalitis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Opsoclonus-Myoclonus Syndrome
1
Neurotoxicity Syndromes
1
Neuromyelitis Optica
1
Neurofibromatosis 1
1
Myasthenia Gravis
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Lambert-Eaton Myasthenic Syndrome
1
Intraocular Lymphoma
1
HIV Infections
1
Ependymoma
1
Drug-Related Side Effects and Adverse Reactions
1
Breast Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Interventions
Trastuzumab
20
Radiosurgery
15
Magnetic Resonance Spectroscopy
15
Capecitabine
14
Lapatinib
12
Radiotherapy
11
Specimen Handling
10
Cyclophosphamide
9
trastuzumab deruxtecan
8
Temozolomide
8
Docetaxel
8
Paclitaxel
7
Gemcitabine
6
Cisplatin
6
sacituzumab govitecan
5
Vinorelbine
5
Therapeutics
5
Spinal Puncture
5
Flow Cytometry
5
tucatinib
4
pembrolizumab
4
paclitaxel-Angiopep-2 conjugate
4
eribulin
4
Methotrexate
4
Irinotecan
4
Fluorodeoxyglucose F18
4
Dexamethasone
4
Bevacizumab
4
temsirolimus
3
pyrotinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Cytarabine
×
CNS
×
Clear all
NCT01645839
2019-06-12
DEPOSEIN
Centre Oscar Lambret
Phase 3
Completed
74 enrolled